These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29238043)

  • 1. BCL-X
    Trisciuoglio D; Tupone MG; Desideri M; Di Martile M; Gabellini C; Buglioni S; Pallocca M; Alessandrini G; D'Aguanno S; Del Bufalo D
    Cell Death Dis; 2017 Dec; 8(12):3216. PubMed ID: 29238043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HNRNPA2B1 stabilizes NFATC3 levels to potentiate its combined actions with FOSL1 to mediate vasculogenic mimicry in GBM cells.
    Wang H; Shi Y; Zhou X; Zhang L; Yang A; Zhou D; Ma T
    Cell Biol Toxicol; 2024 Jun; 40(1):44. PubMed ID: 38862832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma.
    Sharma I; Singh A; Siraj F; Saxena S
    J Biomed Sci; 2018 Aug; 25(1):62. PubMed ID: 30086759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma.
    Nguyen TT; Torrini C; Shang E; Shu C; Mun JY; Gao Q; Humala N; Akman HO; Zhang G; Westhoff MA; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38483541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.
    Latha K; Li M; Chumbalkar V; Gururaj A; Hwang Y; Dakeng S; Sawaya R; Aldape K; Cavenee WK; Bogler O; Furnari FB
    Int J Cancer; 2013 Feb; 132(3):509-20. PubMed ID: 22729867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of mitochondrial NAD
    Son MJ; Ryu JS; Kim JY; Kwon Y; Chung KS; Mun SJ; Cho YS
    Exp Mol Med; 2017 Jun; 49(6):e344. PubMed ID: 28604662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor activating enhancer-binding protein 2ε (AP2ε) modulates phenotypic plasticity and progression of malignant melanoma.
    Staebler S; Rottensteiner-Brandl U; El Ahmad Z; Kappelmann-Fenzl M; Arkudas A; Kengelbach-Weigand A; Bosserhoff AK; Schmidt SK
    Cell Death Dis; 2024 May; 15(5):351. PubMed ID: 38773108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANKZF1 knockdown inhibits glioblastoma progression by promoting intramitochondrial protein aggregation through mitoRQC.
    Li G; Wang Z; Gao B; Dai K; Niu X; Li X; Wang Y; Li L; Wu X; Li H; Yu Z; Wang Z; Chen G
    Cancer Lett; 2024 Jun; 591():216895. PubMed ID: 38670305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas.
    Choi SH; Tamura K; Khajuria RK; Bhere D; Nesterenko I; Lawler J; Shah K
    Mol Ther; 2024 May; 32(5):1595. PubMed ID: 38702134
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer.
    D'Aguanno S; Del Bufalo D
    Cells; 2020 May; 9(5):. PubMed ID: 32455818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.
    Boise LH; González-García M; Postema CE; Ding L; Lindsten T; Turka LA; Mao X; Nuñez G; Thompson CB
    Cell; 1993 Aug; 74(4):597-608. PubMed ID: 8358789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer.
    Maji S; Panda S; Samal SK; Shriwas O; Rath R; Pellecchia M; Emdad L; Das SK; Fisher PB; Dash R
    Adv Cancer Res; 2018; 137():37-75. PubMed ID: 29405977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the roles of antiapoptotic members of the Bcl-2 family in melanoma progression and therapy.
    Trisciuoglio D; Del Bufalo D
    Drug Discov Today; 2021 May; 26(5):1126-1135. PubMed ID: 33545382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma.
    Di Martile M; Desideri M; Tupone MG; Buglioni S; Antoniani B; Mastroiorio C; Falcioni R; Ferraresi V; Baldini N; Biagini R; Milella M; Trisciuoglio D; Del Bufalo D
    Oncogenesis; 2018 Feb; 7(2):20. PubMed ID: 29472530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 dependent modulation of Hippo pathway in cancer cells.
    D'Aguanno S; Brignone M; Scalera S; Chiacchiarini M; Di Martile M; Valentini E; De Nicola F; Ricci A; Pelle F; Botti C; Maugeri-Saccà M; Del Bufalo D
    Cell Commun Signal; 2024 May; 22(1):277. PubMed ID: 38755629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Melanoma Effects of Miconazole: Investigating the Mitochondria Involvement.
    Scatozza F; Giardina MM; Valente C; Vigiano Benedetti V; Facchiano A
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data.
    Kotlov N; Shaposhnikov K; Tazearslan C; Chasse M; Baisangurov A; Podsvirova S; Fernandez D; Abdou M; Kaneunyenye L; Morgan K; Cheremushkin I; Zemskiy P; Chelushkin M; Sorokina M; Belova E; Khorkova S; Lozinsky Y; Nuzhdina K; Vasileva E; Kravchenko D; Suryamohan K; Nomie K; Curran J; Fowler N; Bagaev A
    Commun Biol; 2024 Mar; 7(1):392. PubMed ID: 38555407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL.
    Nayak D; Lv D; Yuan Y; Zhang P; Hu W; Nayak A; Ruben EA; Lv Z; Sung P; Hromas R; Zheng G; Zhou D; Olsen SK
    Nat Commun; 2024 Mar; 15(1):2743. PubMed ID: 38548768
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Joshi AS; Bapat MV; Singh P; Mijakovic I
    Mater Today Bio; 2024 Apr; 25():100997. PubMed ID: 38379934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of YY1 in the Regulation of Anti-Apoptotic Gene Products in Drug-Resistant Cancer Cells.
    Jung M; Bui I; Bonavida B
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.